A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease von Turner, R Scott, Thomas, Ronald G, Craft, Suzanne, van Dyck, Christopher H, Mintzer, Jacobo, Reynolds, Brigid A, Brewer, James B, Rissman, Robert A, Raman, Rema, Aisen, Paul S

Volltext

A phase 3 trial of IV immunoglobulin for Alzheimer disease von Relkin, Norman R, Thomas, Ronald G, Rissman, Robert A, Brewer, James B, Rafii, Michael S, van Dyck, Christopher H, Jack, Clifford R, Sano, Mary, Knopman, David S, Raman, Rema, Szabo, Paul, Gelmont, David M, Fritsch, Sandor, Aisen, Paul S

Volltext

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease von Galasko, Douglas, Bell, Joanne, Mancuso, Jessica Y, Kupiec, James W, Sabbagh, Marwan N, van Dyck, Christopher, Thomas, Ronald G, Aisen, Paul S

Volltext

A phase II trial of huperzine A in mild to moderate Alzheimer disease von Rafii, M S, Walsh, S, Little, J T, Behan, K, Reynolds, B, Ward, C, Jin, S, Thomas, R, Aisen, P S

Volltext

Chronic divalproex sodium use and brain atrophy in Alzheimer disease von FLEISHER, A. S, TRURAN, D, TARIOT, P. N, MAI, J. T, LANGBAUM, J. B. S, AISEN, P. S, CUMMINGS, J. L, JACK, C. R, WEINER, M. W, THOMAS, R. G, SCHNEIDER, L. S

Volltext

T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease von Shadyab, Aladdin H., LaCroix, Andrea Z., Matthews, Genevieve, Bennett, Daniel, Shadyab, Alexandre A., Tan, Donna, Thomas, Ronald G., Mason, Jennifer, Lopez, Alex, Askew, Brianna, Donahue, Lia, Kaplita, Stephen, Qureshi, Irfan A., Huisa, Branko, Feldman, Howard H.

Volltext

Development of a novel cognitive composite outcome to assess therapeutic effects of exercise in the EXERT trial for adults with MCI: The ADAS‐Cog‐Exec von Jacobs, Diane M., Thomas, Ronald G., Salmon, David P., Jin, Shelia, Feldman, Howard H., Cotman, Carl W., Baker, Laura D.

Volltext

A randomized clinical trial to evaluate home-based assessment of people over 75 years old von Sano, Mary, Zhu, Carolyn W., Kaye, Jeffrey, Mundt, James C., Hayes, Tamara L., Ferris, Steven, Thomas, Ronald G., Sun, Chung-Kai, Jiang, Yanxin, Donohue, Michael C., Schneider, Lon S., Egelko, Susan, Aisen, Paul S., Feldman, Howard H.

Volltext

Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial von Schneider, Lon S, Thomas, Ronald G, Hendrix, Suzanne, Rissman, Robert A, Brewer, James B, Salmon, David P, Oltersdorf, Tilman, Okuda, Tomohiro, Feldman, Howard H

Volltext

Research Attitudes Questionnaire scores predict Alzheimer’s disease clinical trial dropout von Stites, Shana D, Turner, R Scott, Gill, Jeanine, Gurian, Anna, Karlawish, Jason, Grill, Joshua D

Volltext

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials von Nuño, Michelle M, Gillen, Daniel L, Grill, Joshua D

Volltext

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial von Mulnard, Ruth A, Cotman, Carl W, Kawas, Claudia, van Dyck, Christopher H, Sano, Mary, Doody, Rachelle, Koss, Elizabeth, Pfeiffer, Eric, Jin, Shelia, Gamst, Anthony, Grundman, Michael, Thomas, Ronald, Thal, Leon J, for the Alzheimer's Disease Cooperative Study

Volltext

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's disease von Doody, Rachelle S, Raman, Rema, Sperling, Reisa A, Seimers, Eric, Sethuraman, Gopalan, Mohs, Richard, Farlow, Martin, Iwatsubo, Takeshi, Vellas, Bruno, Sun, Xiaoying, Ernstrom, Karin, Thomas, Ronald G, Aisen, Paul S

Volltext

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease von Doody, Rachelle S, Raman, Rema, Farlow, Martin, Iwatsubo, Takeshi, Vellas, Bruno, Joffe, Steven, Kieburtz, Karl, He, Feng, Sun, Xiaoying, Thomas, Ronald G, Aisen, Paul S, Siemers, Eric, Sethuraman, Gopalan, Mohs, Richard

Volltext

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease von Doody, Rachelle S, Thomas, Ronald G, Farlow, Martin, Iwatsubo, Takeshi, Vellas, Bruno, Joffe, Steven, Kieburtz, Karl, Raman, Rema, Sun, Xiaoying, Aisen, Paul S, Siemers, Eric, Liu-Seifert, Hong, Mohs, Richard

Volltext

Divalproex Sodium in Nursing Home Residents With Possible or Probable Alzheimer Disease Complicated by Agitation von Tariot, Pierre N., Raman, Rema, Jakimovich, Laura, Schneider, Lon, Porsteinsson, Anton, Thomas, Ronald, Mintzer, Jacobo, Brenner, Ronald, Schafer, Kim, Thal, Leon

Volltext

Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial von Aisen, Paul S, Schafer, Kimberly A, Grundman, Michael, Pfeiffer, Eric, Sano, Mary, Davis, Kenneth L, Farlow, Martin R, Jin, Shelia, Thomas, Ronald G, Thal, Leon J

Volltext

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment von Petersen, Ronald C, Thomas, Ronald G, Grundman, Michael, Bennett, David, Doody, Rachelle, Ferris, Steven, Galasko, Douglas, Jin, Shelia, Kaye, Jeffrey, Levey, Allan, Pfeiffer, Eric, Sano, Mary, van Dyck, Christopher H, Thal, Leon J

Volltext

High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Controlled Trial von Aisen, Paul S, Schneider, Lon S, Sano, Mary, Diaz-Arrastia, Ramon, van Dyck, Christopher H, Weiner, Myron F, Bottiglieri, Teodoro, Jin, Shelia, Stokes, Karen T, Thomas, Ronald G, Thal, Leon J, Alzheimer Disease Cooperative Study, for the

Volltext

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment von FLEISHER, A. S, SOWELL, B. B, TAYLOR, C, GAMST, A. C, PETERSEN, R. C, THAI, L. J

Volltext